Beaumont Health - Grosse Pointe
- Type
- Teaching hospital
- Where
- GROSSE POINTE, MI
- Medicare CCN
- 230089
- Received
- $535,291 in 88 records, 2023 ($237,080 general, $298,210 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 56 | $237,080 |
| 2023 | Research payment | 32 | $298,210 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Ablacon, Inc. | 1 | $142,447 | 2023 |
| Abbott Laboratories | 11 | $98,243 | 2023 |
| Edwards Lifesciences Corporation | 10 | $51,497 | 2023 |
| Boston Scientific Corporation | 17 | $48,602 | 2023 |
| AngioDynamics, Inc. | 1 | $34,333 | 2023 |
| Providence Medical Technology, Inc. | 6 | $29,535 | 2023 |
| Ipsen Pharma SAS | 8 | $23,888 | 2023 |
| Roche TCRC, Inc. | 1 | $21,396 | 2023 |
| Elekta Limited | 1 | $16,750 | 2023 |
| Janssen Pharmaceuticals, Inc | 3 | $10,500 | 2023 |
| GE HEALTHCARE | 3 | $9,675 | 2023 |
| Smith+Nephew, Inc. | 5 | $9,503 | 2023 |
| MML US, Inc. | 2 | $9,307 | 2023 |
| Actelion Pharmaceuticals US, Inc. | 2 | $8,500 | 2023 |
| Medtronic, Inc. | 1 | $4,000 | 2023 |
| Daiichi Sankyo Inc. | 2 | $4,000 | 2023 |
| National Marrow Donor Program | 2 | $2,380 | 2023 |
| ABBVIE INC. | 2 | $2,000 | 2023 |
| Medical Device Business Services, Inc. | 1 | $1,937 | 2023 |
| Linde Gas & Equipment Inc. | 5 | $1,897 | 2023 |
| Eli Lilly and Company | 1 | $1,745 | 2023 |
| Lilly USA, LLC | 1 | $1,350 | 2023 |
| Neurelis, Inc. | 1 | $1,250 | 2023 |
| Stryker Corporation | 1 | $551 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 32 | $298,210 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 12 | $81,832 |
| Space rental or facility fees (teaching hospital only) | 27 | $68,188 |
| Grant | 11 | $38,500 |
| Long term medical supply or device loan | 2 | $34,884 |
| Consulting Fee | 1 | $8,000 |
| Debt forgiveness | 2 | $4,425 |
| Education | 1 | $1,250 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | AngioDynamics, Inc. | $34,333 | Long term medical supply or device loan | In-kind items and services | NanoKnife Device, Oncology Surgery | 2023 | |
| 2023-12-31 | Medtronic, Inc. | $4,000 | Debt forgiveness | Cash or cash equivalent | MYCARELINK Device, Cardiac Diagnostics and Monitoring | 2023 | |
| 2023-12-31 | Stryker Corporation | $551 | Long term medical supply or device loan | In-kind items and services | ISOTOUR Device, PATIENT CARE - PC | 2023 | |
| 2023-12-22 | Boston Scientific Corporation | $4,000 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-12-22 | Boston Scientific Corporation | $4,000 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-12-22 | Boston Scientific Corporation | $4,000 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-12-21 | Edwards Lifesciences Corporation | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2023 | |
| 2023-12-19 | Abbott Laboratories | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ARCHITECT Device, Core Diagnostics | 2023 | |
| 2023-12-18 | Abbott Laboratories | $1,725 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ARCHITECT Device, Core Diagnostics | 2023 | |
| 2023-12-14 | Ipsen Pharma SAS | $2,732 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-12-14 | Ipsen Pharma SAS | $1,303 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-12-14 | Ipsen Pharma SAS | $1,190 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-12-11 | Ipsen Pharma SAS | $2,912 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-11-29 | Abbott Laboratories | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INFINITY Device, Neuromodulation | 2023 | |
| 2023-11-17 | Boston Scientific Corporation | $2,000 | Grant | In-kind items and services | Device, General - Therapies_EP | 2023 | |
| 2023-11-13 | Abbott Laboratories | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PERCLOSE PROSTYLE Device, Vascular | 2023 | |
| 2023-11-13 | Edwards Lifesciences Corporation | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2023 | |
| 2023-11-09 | Janssen Pharmaceuticals, Inc | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-11-03 | Actelion Pharmaceuticals US, Inc. | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | OPSUMIT Drug, Cardiology | 2023 | |
| 2023-11-02 | Edwards Lifesciences Corporation | $4,889 | Research payment | Cash or cash equivalent | CLASP II TR Pivotal, Study No. 2019-07 | 2023 | |
| 2023-11-02 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, Respiratory | 2023 | |
| 2023-11-01 | Providence Medical Technology, Inc. | $435 | Research payment | In-kind items and services | Fuse Study | 2023 | |
| 2023-10-31 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, Respiratory | 2023 | |
| 2023-10-28 | Linde Gas & Equipment Inc. | $313 | Space rental or facility fees (teaching hospital only) | In-kind items and services | NXBPUMP-FLO-MTR Device, Respiratory | 2023 | |
| 2023-10-20 | National Marrow Donor Program | $830 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-10-19 | ABBVIE INC. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-10-18 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, Respiratory | 2023 | |
| 2023-10-16 | Janssen Pharmaceuticals, Inc | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-10-16 | GE HEALTHCARE | $425 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-10-14 | Linde Gas & Equipment Inc. | $594 | Space rental or facility fees (teaching hospital only) | In-kind items and services | NXBREG081 Device, Respiratory | 2023 | |
| 2023-10-09 | ABBVIE INC. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-10-05 | Ablacon, Inc. | $142,447 | Research payment | In-kind items and services | RESOLVE-AF | 2023 | |
| 2023-10-05 | Medical Device Business Services, Inc. | $1,937 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2023 | ||
| 2023-10-04 | GE HEALTHCARE | $8,000 | Consulting Fee | Cash or cash equivalent | ApexPro Device, Patient Monitoring | 2023 | |
| 2023-10-04 | Lilly USA, LLC | $1,350 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2023 | ||
| 2023-09-28 | Smith+Nephew, Inc. | $1,750 | Research payment | Cash or cash equivalent | Bone Anchors with Arthroscopic Delivery System Device, Extremities & Limb Restoration | Prospective Multi-Center Study Comparing REGENETEN in Lieu of Standard Arthroscopic Repair of high grade (>50%) partial | 2023 |
| 2023-09-18 | Janssen Pharmaceuticals, Inc | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-09-15 | Actelion Pharmaceuticals US, Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | UPTRAVI Drug, Cardiology | 2023 | |
| 2023-09-11 | Eli Lilly and Company | $1,745 | Research payment | In-kind items and services | EMBER-4: A RANDOMIZED OPEN-LABEL PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIEN | 2023 | |
| 2023-09-08 | Neurelis, Inc. | $1,250 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2023 | |
| 2023-09-05 | Edwards Lifesciences Corporation | $416 | Research payment | Cash or cash equivalent | PARTNER II (2010-12) | 2023 | |
| 2023-08-31 | Edwards Lifesciences Corporation | $16,812 | Research payment | Cash or cash equivalent | CLASP II TR Pivotal, Study No. 2019-07 | 2023 | |
| 2023-08-24 | Edwards Lifesciences Corporation | $10,000 | Research payment | Cash or cash equivalent | CLASP II TR Pivotal, Study No. 2019-07 | 2023 | |
| 2023-08-22 | Abbott Laboratories | $9,000 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-08-16 | Providence Medical Technology, Inc. | $10,000 | Research payment | Cash or cash equivalent | Fuse Study | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $1,201 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-11 | Boston Scientific Corporation | $901 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AVVIGO Guidance System Device, AVVIGO_IC | 2023 | |
| 2023-08-04 | National Marrow Donor Program | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-08-02 | Providence Medical Technology, Inc. | $2,050 | Research payment | In-kind items and services | Fuse Study | 2023 | |
| 2023-08-01 | GE HEALTHCARE | $1,250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | DaTscan Drug, Pharma Imaging Agents - Nuclear Imaging | 2023 | |
| 2023-07-31 | Edwards Lifesciences Corporation | $871 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2023 | |
| 2023-07-31 | Abbott Laboratories | $280 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | AMPLATZER Amulet LAA Occluder Trial (Amulet IDE) | 2023 |
| 2023-07-05 | Providence Medical Technology, Inc. | $4,525 | Research payment | In-kind items and services | Fuse Study | 2023 | |
| 2023-07-03 | Edwards Lifesciences Corporation | $2,506 | Research payment | Cash or cash equivalent | CLASP II TR Pivotal, Study No. 2019-07 | 2023 | |
| 2023-06-30 | Smith+Nephew, Inc. | $2,183 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ACUFEX Meniscal Root Repair Device, Sports Med Knee | 2023 | |
| 2023-06-30 | Smith+Nephew, Inc. | $2,097 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BIOSURE Device, Sports Med Knee | 2023 | |
| 2023-06-30 | Smith+Nephew, Inc. | $1,972 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | NovoStitch Device, Sports Med Knee | 2023 | |
| 2023-06-12 | Ipsen Pharma SAS | $12,000 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-06-12 | Ipsen Pharma SAS | $1,500 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-06-12 | Ipsen Pharma SAS | $750 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety | 2023 |
| 2023-05-10 | Elekta Limited | $16,750 | Research payment | Cash or cash equivalent | ELEKTA MEDICAL LINEAR ACCELERATOR Device, LINAC SOLUTIONS (LINAC) | Deep Learning Based Auto Segmentation and Synthetic CT | 2023 |
| 2023-05-08 | Roche TCRC, Inc. | $21,396 | Research payment | Cash or cash equivalent | Antibiotics MCP patient PK study | 2023 | |
| 2023-04-26 | Abbott Laboratories | $4,033 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | AMPLATZER Amulet LAA Occluder Trial (Amulet IDE) | 2023 |
| 2023-04-19 | Providence Medical Technology, Inc. | $5,750 | Research payment | In-kind items and services | Fuse Study | 2023 | |
| 2023-03-30 | Daiichi Sankyo Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | INJECTAFER Drug, Iron Deficiency Anemia | 2023 | |
| 2023-03-20 | Daiichi Sankyo Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | INJECTAFER Drug, Iron Deficiency Anemia | 2023 | |
| 2023-03-14 | Edwards Lifesciences Corporation | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves | 2023 | |
| 2023-03-08 | Abbott Laboratories | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PERCLOSE PROSTYLE Device, Vascular | 2023 | |
| 2023-03-03 | Providence Medical Technology, Inc. | $6,775 | Research payment | In-kind items and services | Fuse Study | 2023 | |
| 2023-03-03 | Ipsen Pharma SAS | $1,500 | Research payment | Cash or cash equivalent | Dysport Drug, Neurology | International, Multicentre, Observational, Prospective, Longitudinal Study to Assess the Effectiveness of AboBoNT-A Inje | 2023 |
| 2023-02-17 | Boston Scientific Corporation | $2,500 | Grant | Cash or cash equivalent | Device, General - Structural Heart_IC | 2023 | |
| 2023-02-14 | Smith+Nephew, Inc. | $1,500 | Research payment | Cash or cash equivalent | Bone Anchors with Arthroscopic Delivery System Device, Extremities & Limb Restoration | Prospective Multi-Center Study Comparing REGENETEN in Lieu of Standard Arthroscopic Repair of high grade (>50%) partial | 2023 |
| 2023-02-10 | Boston Scientific Corporation | $6,000 | Grant | In-kind items and services | Device, General - Brady_CRM | 2023 | |
| 2023-02-03 | Boston Scientific Corporation | $3,000 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-02-03 | Boston Scientific Corporation | $3,000 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-02-01 | Abbott Laboratories | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | 2023 | |
| 2023-02-01 | Abbott Laboratories | $1,080 | Research payment | Cash or cash equivalent | AMPLATZER AMULET Device, Structural Heart | AMPLATZER Amulet LAA Occluder Trial (Amulet IDE) | 2023 |
| 2023-01-30 | Edwards Lifesciences Corporation | $6,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves | 2023 | |
| 2023-01-27 | Boston Scientific Corporation | $1,250 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-01-27 | Boston Scientific Corporation | $1,250 | Grant | In-kind items and services | Device, General - Catheter_IC | 2023 | |
| 2023-01-17 | Abbott Laboratories | $65,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ALINITY Device, CORE DIAGNOSTICS | 2023 | |
| 2023-01-13 | Boston Scientific Corporation | $7,500 | Grant | Cash or cash equivalent | Device, General - EP_EP | 2023 | |
| 2023-01-05 | MML US, Inc. | $6,791 | Research payment | Cash or cash equivalent | ReActiv8 Device, Pain Management | B Trial | 2023 |
| 2023-01-05 | MML US, Inc. | $2,516 | Research payment | Cash or cash equivalent | ReActiv8 Device, Pain Management | B Trial | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Grosse Pointe, MI, county Wayne County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Grosse Pointe, MI | County Wayne County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 5,541 | 1,772,259 | 10,077,761 |
| Population, 2020 census P1 | 5,678 | 1,793,561 | 10,077,331 |
| Median age B01002 | 43.8 | 37.9 | 40.2 |
| Under 18 B01001 | 26.6% | 23.6% | 21.2% |
| 65 and over B01001 | 23.2% | 16.6% | 18.6% |
| Households B11001 | 2,211 | 700,591 | 4,076,369 |
| Foreign born B05002 | 7.8% | 10.3% | 7.2% |
| Median household income B19013 | $158,853 | $60,539 | $72,875 |
| Median family income B19113 | $180,357 | $79,522 | $93,357 |
| Per capita income B19301 | $86,088 | $34,906 | $40,735 |
| Poverty rate B17001 | 2.8% | 20.8% | 13.2% |
| Unemployment rate B23025 | 4.3% | 8.7% | 5.7% |
| Civilian labor force B23025 | 2,769 | 828,838 | 5,018,449 |
| Mean commute (minutes) B08013 | 24.4 | 24.7 | 24.2 |
| Bachelor's degree or higher B15003 | 73.1% | 27.6% | 32.4% |
| Housing units B25001 | 2,452 | 801,083 | 4,622,236 |
| Owner-occupied B25003 | 85.9% | 64.8% | 73.2% |
| Renters B25003 | 14.1% | 35.2% | 26.8% |
| Median home value B25077 | $436,800 | $178,500 | $231,600 |
| Median gross rent B25064 | $1,725 | $1,132 | $1,129 |
| White, not Hispanic B03002 | 91.0% | 47.9% | 72.4% |
| Black B03002 | 1.5% | 36.6% | 13.1% |
| Hispanic or Latino B03002 | 3.1% | 6.9% | 5.9% |
| Asian B03002 | 1.0% | 3.7% | 3.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Grosse Pointe, MI.
Comments